ArticleNanomaterials (Basel, Switzerland)2019
Upgrading of Extra-Heavy Crude Oils by Dispersed Injection of NiO-PdO/CeO
Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 41 citations in OpenAlex.
- Development of Nanofluid-Based Solvent as a Hybrid Technology for In-Situ Heavy Oil Upgrading During Cyclic Steam Stimulation Applications.ACS omega · 2024Article
- Catalytic Conversion ofNanomaterials (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
The main objective of this study is to evaluate the injection of a dispersed nanocatalyst-based nanofluid in a steam stream for in situ upgrading and oil recovery during a steam injection process. The nanocatalyst was selected through adsorption and thermogravimetric experiments. Two nanoparticles were proposed, ceria nanoparticles (CeO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.